DCF Advisers’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-157,665
| Closed | -$2.39M | – | 75 |
|
|
2022
Q3 | $2.39M | Sell |
157,665
-9,500
| -6% | -$144K | 1.54% | 20 |
|
|
2022
Q2 | $1.25M | Sell |
167,165
-22,400
| -12% | -$168K | 0.75% | 34 |
|
|
2022
Q1 | $1.73M | Sell |
189,565
-2,500
| -1% | -$22.7K | 0.76% | 32 |
|
|
2021
Q4 | $1.35M | Buy |
192,065
+55,564
| +41% | +$390K | 0.55% | 37 |
|
|
2021
Q3 | $1.56M | Buy |
136,501
+45,201
| +50% | +$515K | 0.69% | 35 |
|
|
2021
Q2 | $1.46M | Sell |
91,300
-1,200
| -1% | -$19.2K | 0.52% | 33 |
|
|
2021
Q1 | $1.65M | Buy |
92,500
+57,500
| +164% | +$1.03M | 0.72% | 31 |
|
|
2020
Q4 | $473K | Buy |
+35,000
| New | +$473K | 0.2% | 58 |
|
|
2020
Q1 | – | Sell |
-20,500
| Closed | -$495K | – | 73 |
|
|
2019
Q4 | $495K | Buy |
+20,500
| New | +$495K | 0.31% | 40 |
|